Search
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20221 results available
- November 20221 results available
- October 20222 results available
- September 20221 results available
- August 20221 results available
- June 20221 results available
- April 20223 results available
- February 20224 results available
- January 20222 results available
Recall class
Displaying 16 - 16 of 16 items.
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
AlertHealth professional risk communication | 2022-01-07